These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34057456)

  • 1. Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles.
    Truffi M; Sitia L; Sevieri M; Bonizzi A; Rizzuto MA; Mazzucchelli S; Corsi F
    J Vis Exp; 2021 May; (171):. PubMed ID: 34057456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhein and hesperidin nanoparticles remodel tumor immune microenvironment by reducing CAFs and CCL2 secreted by CAAs for efficient triple-negative breast cancer therapy.
    Huang J; Zhang H; Ma L; Ma N; Luo N; Jin W; Shi J; Xu S; Xiong Y
    Int Immunopharmacol; 2024 Nov; 141():113001. PubMed ID: 39186835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Isolation from Mammary Gland Tissue and Syngeneic Murine Breast Cancer Models.
    Bartish M; Smith-Voudouris J; Del Rincón SV
    Methods Mol Biol; 2023; 2614():171-185. PubMed ID: 36587126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis.
    Li C; Wang Z; Zhang Y; Zhu Y; Xu M; Lei H; Zhang D
    Int J Nanomedicine; 2024; 19():1749-1766. PubMed ID: 38414527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer.
    Houthuijzen JM; de Bruijn R; van der Burg E; Drenth AP; Wientjens E; Filipovic T; Bullock E; Brambillasca CS; Pulver EM; Nieuwland M; de Rink I; van Diepen F; Klarenbeek S; Kerkhoven R; Brunton VG; Scheele CLGJ; Boelens MC; Jonkers J
    Nat Commun; 2023 Jan; 14(1):183. PubMed ID: 36635273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer.
    Venning FA; Zornhagen KW; Wullkopf L; Sjölund J; Rodriguez-Cupello C; Kjellman P; Morsing M; Hajkarim MC; Won KJ; Erler JT; Madsen CD
    J Exp Clin Cancer Res; 2021 May; 40(1):175. PubMed ID: 34016130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomimetic "nano-spears" for CAFs-targeting: splintered three "shields" with enhanced cisplatin anti-TNBC efficiency.
    Wu Y; Chen R; Ni S; Hu K
    J Control Release; 2024 Jun; 370():556-569. PubMed ID: 38697316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax.
    Sitia L; Bonizzi A; Mazzucchelli S; Negri S; Sottani C; Grignani E; Rizzuto MA; Prosperi D; Sorrentino L; Morasso C; Allevi R; Sevieri M; Silva F; Truffi M; Corsi F
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic Nanoplatform for Dual-Targeted Clearance of Activated and Senescent Cancer-Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer.
    Jian C; Wu T; Wang L; Gao C; Fu Z; Zhang Q; Shi C
    Small; 2024 Jun; 20(25):e2309279. PubMed ID: 38214439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhein potentiates doxorubicin in treating triple negative breast cancer by inhibiting cancer-associated fibroblasts.
    Xu S; Zheng S; Ma N; Zhang H; Shi J; Huang J; Luo N; Wang M; Xiong Y
    Biochem Pharmacol; 2024 May; 223():116139. PubMed ID: 38499109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
    Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.
    Baroni S; Romero-Cordoba S; Plantamura I; Dugo M; D'Ippolito E; Cataldo A; Cosentino G; Angeloni V; Rossini A; Daidone MG; Iorio MV
    Cell Death Dis; 2016 Jul; 7(7):e2312. PubMed ID: 27468688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis.
    Cao Y; Cao W; Qiu Y; Zhou Y; Guo Q; Gao Y; Lu N
    Pharmacol Res; 2020 Sep; 159():104981. PubMed ID: 32492489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer.
    Salimifard S; Masjedi A; Hojjat-Farsangi M; Ghalamfarsa G; Irandoust M; Azizi G; Mohammadi H; Keramati MR; Jadidi-Niaragh F
    Pathol Res Pract; 2020 May; 216(5):152915. PubMed ID: 32146002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues.
    Elwakeel E; Weigert A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets.
    Lappano R; Rigiracciolo DC; Belfiore A; Maggiolini M; De Francesco EM
    Expert Opin Ther Targets; 2020 Jun; 24(6):559-572. PubMed ID: 32249708
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment.
    McDonald LT; Russell DL; Kelly RR; Xiong Y; Motamarry A; Patel RK; Jones JA; Watson PM; Turner DP; Watson DK; Soloff AC; Findlay VJ; LaRue AC
    Neoplasia; 2015 May; 17(5):434-48. PubMed ID: 26025666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.